期刊文献+

术前癌胚抗原水平对结肠癌预后的预测价值 被引量:2

原文传递
导出
摘要 为了评估行择期根治性手术结肠癌患者术前高癌胚抗原(CEA)水平与预后的关系,Kirat HT等对1980~2008年期间行根治性手术的651例结肠癌患者的临床资料进行了回顾性分析。其中男379例,女272例;年龄21~94岁,平均年龄为67岁;中位随访时间为5.9年。根据术前CEA水平将患者分为低水平组(≤5 mg/L)和高水平组(〉5 mg/L),分别为451例和200例。2组患者的年龄和肿瘤位置比较差异均无统计学意义;但高水平组患者的肿瘤较大,
作者 董亚婕
出处 《中国普外基础与临床杂志》 CAS 2013年第6期663-663,共1页 Chinese Journal of Bases and Clinics In General Surgery
  • 相关文献

同被引文献27

  • 1夏廷毅,李宏奇,王颖杰,李平,孙庆选,范乃斌,于勇.全身γ刀治疗不能手术Ⅰ和Ⅱ期非小细胞肺癌的临床结果[J].中华放射肿瘤学杂志,2007,16(2):91-97. 被引量:57
  • 2Matsuo Y,Chen F,Hamaji M,et al. Comparison of long- term survival outcomes between stereotactic body radio- therapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy:A propensity score matching analysis[J]. Eur J Cancer, 2014,50(17) : 2932-2938.
  • 3Iyengar P,Kavanagh BD,Wardak Z,et al. Phase II trial of stereotactic body radiation therapy combined with er- lotinib for patients with limited but progressive metastatic non-small-cell lung cancer[J]. J Clin Oncol,2014,32 (34) : 3824-3830.
  • 4Rule W,Timmerman R,Tong L,et al. Phase Idose-es- calation study of stereotactic body radiotherapy in pa- tients with hepatic metastases[J]. Annal Surg Oncol, 2011,18(4) : 1081-1087.
  • 5Pham D, Thompson A, Kron T, et al. Stereotaetic ablative body radiation therapy for primary kidney cancer:a 3-di- mensional conformal technique associated with low rates of early toxicity[J]. Int J Radiat Oncol Biol Phys,2014,90 (5) : 1061-1068.
  • 6Yuan ZY, Meng MB, Liu CL, et al. Stereotactic body radi- ation therapy using the CyberKnife(~)system for patients with liver metastases [J]. Onco Targets Ther, 2014,12 (7) :915-923.
  • 7Franks KN,Jain P,Snee MP. Stereotactic ablative body radiotherapy for lung cancer[J]. Clin Oncol (R Coll Ra- diol) ,2015,27(5) :280-289.
  • 8Furman MJ, Whalen GF, Shah SA, et al. Gastric perfora- tion following stereotactic body radiation therapy of hep- atic metastasis from colon cancer[J ]. Pract Radiat Oncol, 2013,3(1) :40-44.
  • 9Davis JN,Medbery C 3rd,Sharma S,et al. Stereotactic body radiotherapy for early-stage non-small cell lung can- cer:clinical outcomes from a national patient registry[J]. J Radiat Oncol,2015,4(1) :55-63.
  • 10Lee MT,Kim JJ,Dinniwell R,et al. Phase I study of indi- vidualized stereotactic body radiotherapy of liver metas- tases[J]. J Clin Oncol, 2009,27(10):1585-1591.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部